Related Experiment Video
Updated: Mar 28, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
STAT3-Interacting Proteins as Modulators of Transcription Factor Function: Implications to Targeted Cancer Therapy
Jennifer E Yeh1, David A Frank2
1Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.
Abstract:
The oncogenic transcription factor STAT3 is inappropriately activated in multiple hematopoietic and solid malignancies, in which it drives the expression of genes involved in cell proliferation, differentiation, survival, and angiogenesis. Thus far, strategies to inhibit the function of STAT3 have focused on blocking the function of its activating kinases or sequestering its DNA binding ability. A less well-explored aspect of STAT3 function is its interaction with other proteins, which can modulate the oncogenic activity of STAT3 via its subcellular localization, DNA binding ability, and recruitment of transcriptional machinery. Herein we summarize what is currently known about STAT3-interacting proteins and describe the utility of a proteomics-based approach for successfully identifying and characterizing novel STAT3-interacting proteins that affect STAT3 transcriptional activity and oncogenic function.
Insights
Signal transducer and activator of transcription 3 (STAT3) is a key oncogenic factor in many cancers. This study explores STAT3-interacting proteins, identifying novel targets to inhibit its cancer-promoting functions.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Signal transducer and activator of transcription 3 (STAT3) is a transcription factor crucial for cell processes.
- Aberrant STAT3 activation is implicated in numerous cancers, driving proliferation, survival, and angiogenesis.
- Current inhibition strategies target STAT3 kinases or DNA binding, overlooking protein interactions.
Purpose of the Study:
- To review known STAT3-interacting proteins.
- To highlight the potential of proteomics for discovering novel STAT3 interactors.
- To characterize how these interactions modulate STAT3's oncogenic activity.
Main Methods:
- Literature review of STAT3-interacting proteins.
- Description of proteomics-based approaches for identifying protein interactions.
- Characterization of identified proteins' effects on STAT3 activity.
Main Results:
- STAT3 protein interactions modulate its oncogenic functions.
- Proteomics successfully identifies novel STAT3-interacting proteins.
- These interactions influence STAT3's localization, DNA binding, and transcriptional activity.
Conclusions:
- STAT3 protein interactions represent a promising therapeutic target.
- Proteomics offers a powerful tool for uncovering these interactions.
- Targeting STAT3-protein complexes could offer new cancer treatment strategies.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
11:19Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts
Published on: October 9, 2016
Related Concept Videos
Co-activators and Co-repressors
Co-activators and Co-repressors
Master Transcription Regulators
RNA Polymerase II Accessory Proteins
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression